These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 18348649)

  • 1. Contribution of p53, p63, and p73 to the developmental diseases and cancer.
    Tomkova K; Tomka M; Zajac V
    Neoplasma; 2008; 55(3):177-81. PubMed ID: 18348649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational analysis of the p63/p73L/p51/p40/CUSP/KET gene in human cancer cell lines using intronic primers.
    Hagiwara K; McMenamin MG; Miura K; Harris CC
    Cancer Res; 1999 Sep; 59(17):4165-9. PubMed ID: 10485447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TP63 gene in stress response and carcinogenesis: a broader role than expected.
    Petitjean A; Hainaut P; Caron de Fromentel C
    Bull Cancer; 2006 Dec; 93(12):E126-35. PubMed ID: 17182369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p63: Molecular complexity in development and cancer.
    Westfall MD; Pietenpol JA
    Carcinogenesis; 2004 Jun; 25(6):857-64. PubMed ID: 15033906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p63: oncogene or tumor suppressor?
    Mills AA
    Curr Opin Genet Dev; 2006 Feb; 16(1):38-44. PubMed ID: 16359856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Germ-line p53 mutations predispose to a wide spectrum of early-onset cancers.
    Nichols KE; Malkin D; Garber JE; Fraumeni JF; Li FP
    Cancer Epidemiol Biomarkers Prev; 2001 Feb; 10(2):83-7. PubMed ID: 11219776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P63 gene mutations and human developmental syndromes.
    Brunner HG; Hamel BC; Bokhoven Hv Hv
    Am J Med Genet; 2002 Oct; 112(3):284-90. PubMed ID: 12357472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Li-Fraumeni syndrome and germ-line mutations of the p53 gene].
    Leblanc T; Soussi T
    Arch Pediatr; 1994 Jan; 1(1):61-70. PubMed ID: 8087224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TP53 family members and human cancers.
    Bénard J; Douc-Rasy S; Ahomadegbe JC
    Hum Mutat; 2003 Mar; 21(3):182-91. PubMed ID: 12619104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families.
    Achatz MI; Olivier M; Le Calvez F; Martel-Planche G; Lopes A; Rossi BM; Ashton-Prolla P; Giugliani R; Palmero EI; Vargas FR; Da Rocha JC; Vettore AL; Hainaut P
    Cancer Lett; 2007 Jan; 245(1-2):96-102. PubMed ID: 16494995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumors associated with p53 germline mutations: a synopsis of 91 families.
    Kleihues P; Schäuble B; zur Hausen A; Estève J; Ohgaki H
    Am J Pathol; 1997 Jan; 150(1):1-13. PubMed ID: 9006316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 compound heterozygosity in a severely affected child with Li-Fraumeni syndrome.
    Quesnel S; Verselis S; Portwine C; Garber J; White M; Feunteun J; Malkin D; Li FP
    Oncogene; 1999 Jul; 18(27):3970-8. PubMed ID: 10435620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High incidence of protein-truncating TP53 mutations in BRCA1-related breast cancer.
    Holstege H; Joosse SA; van Oostrom CT; Nederlof PM; de Vries A; Jonkers J
    Cancer Res; 2009 Apr; 69(8):3625-33. PubMed ID: 19336573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of R337H, a germline TP53 mutation predisposing to multiple cancers, in asymptomatic women participating in a breast cancer screening program in Southern Brazil.
    Palmero EI; Schüler-Faccini L; Caleffi M; Achatz MI; Olivier M; Martel-Planche G; Marcel V; Aguiar E; Giacomazzi J; Ewald IP; Giugliani R; Hainaut P; Ashton-Prolla P
    Cancer Lett; 2008 Mar; 261(1):21-5. PubMed ID: 18248785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 Germline mutation in a patient with Li-Fraumeni Syndrome and three metachronous malignancies.
    Pötzsch C; Voigtländer T; Lübbert M
    J Cancer Res Clin Oncol; 2002 Aug; 128(8):456-60. PubMed ID: 12200603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p63 and epithelial biology.
    Barbieri CE; Pietenpol JA
    Exp Cell Res; 2006 Apr; 312(6):695-706. PubMed ID: 16406339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype.
    Olivier M; Goldgar DE; Sodha N; Ohgaki H; Kleihues P; Hainaut P; Eeles RA
    Cancer Res; 2003 Oct; 63(20):6643-50. PubMed ID: 14583457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [TP53 mutations and molecular epidemiology].
    Otsuka K; Ishioka C
    Gan To Kagaku Ryoho; 2007 May; 34(5):683-9. PubMed ID: 17496437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Directed expression of dominant-negative p73 enables proliferation of cardiomyocytes in mice.
    Ebelt H; Zhang Y; Köhler K; Xu J; Gajawada P; Boettger T; Hollemann T; Müller-Werdan U; Werdan K; Braun T
    J Mol Cell Cardiol; 2008 Sep; 45(3):411-9. PubMed ID: 18634800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p63: defining roles in morphogenesis, homeostasis, and neoplasia of the epidermis.
    King KE; Weinberg WC
    Mol Carcinog; 2007 Aug; 46(8):716-24. PubMed ID: 17477357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.